echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Anesthesia Topics > Lancet: Gabba spray is used for the treatment of chronic pelvic pain.

    Lancet: Gabba spray is used for the treatment of chronic pelvic pain.

    • Last Update: 2020-10-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Globally, 2-24% of women are affected by chronic pelvic pain, and there is no effective treatment.
    Gabba spray has good therapeutic effect on some chronic pain.
    recently assessed the efficacy and safety of gabal spray for patients with chronic pelvic pain without significant pelvic lesions.
    study, conducted in 39 hospitals across the UK, involved women with chronic pelvic pain (with or without pain or difficulty having sex) for at least three months.
    age range of 18-50 years old, laparoscopic examination no obvious pelvic pathological lesions.
    participants were randomly assigned gaba spray (the dose gradually increased to a maximum dose of 2,700 mg per day) or a placebo for a period of 16 weeks.
    of the study was the difference in average pain score (NRS), which assessed the highest pain score and the average pain score, respectively.
    306 patients were involved in the study, including 153 in the Gabba spray group and 153 in the placebo group.
    13-16 weeks, there was no significant difference in the highest average pain scores between the groups.
    NRS pain score was 7.1 in the Gabba spray group and 7.4 in the placebo group.
    the Gabba spraying group compared to the baseline, the average change in pain score was -1.4 and that of the placebo group was .2.
    average NRS pain score was 4.3 in the Gabba spray group and 4.5 in the placebo group, with average variations of −1.1 and −0.9, respectively, compared to the baseline.
    high rates of severe adverse events (7 vs 2%) occurred in the Gabba spray group, with the most common adverse events being dizziness, drowsiness and visual impairment.
    study concluded that gabal spray had no significant effect on reducing pain levels in women with chronic pelvic pain.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.